ClinicalTrials.Veeva

Menu

Robotic Versus Laparoscopic Liver Resection for Hepatocellular Carcinoma

E

Ente Ospedaliero Cantonale, Bellinzona

Status

Completed

Conditions

Hepatocellular Carcinoma

Treatments

Procedure: Minimally invasive liver resection

Study type

Observational

Funder types

Other

Identifiers

NCT06496113
2023-01022 CE 4377

Details and patient eligibility

About

The objective of the study is to investigate the long-term outcomes of minimally invasive liver surgery (robotic vs laparoscopic) for hepatocellular carcinoma patients of stage BCLC 0-A. Data from two tertiary centers for liver surgery will be retrospectively reviewed. Patients will be divided in two cohorts (robot; laparoscopy). The primary endpoint will be recurrence-free and overall survival; secondary endpoints were incidence, pattern, and treatment of recurrences.

Enrollment

196 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients undergoing robotic and laparoscopic resections
  • Histology-confirmed HCC of stage BCLC 0-A
  • Preserved liver function (Child score A-B)
  • Patients >18 years old

Exclusion criteria

  • Hand-assisted procedures
  • Non-elective surgery
  • Intraoperative switch to locoregional therapies (like radiofrequency or microwave ablation)
  • Non-histologically confirmed HCC
  • Mixed hepato-cholangiocarcinoma.

Trial design

196 participants in 2 patient groups

Robotic liver resections
Treatment:
Procedure: Minimally invasive liver resection
Laparoscopic liver resection
Treatment:
Procedure: Minimally invasive liver resection

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems